Unraveling the causal link between inflammatory cytokines and hypertensive renal disease: a Mendelian randomization analysis
- PMID: 40699416
- DOI: 10.1007/s11255-025-04674-0
Unraveling the causal link between inflammatory cytokines and hypertensive renal disease: a Mendelian randomization analysis
Abstract
Purpose: Hypertensive renal disease is a primary contributor to morbidity and death, with inflammation serving a crucial role in its development. Elevated levels of inflammatory cytokines are frequently observed in hypertensive renal disease patients; however, their causal relationship with the disease remains unclear.
Methods: A two-sample Mendelian randomization (MR) analysis was conducted using genetic variants associated with inflammatory cytokine levels obtained from genome-wide association studies (GWAS) of 14,824 healthy participants. Summary statistics for hypertensive renal disease were derived from the FinnGen R10 dataset. The inverse variance weighted (IVW) method was the primary approach for assessing causal effects, complemented by multiple sensitivity analyses to ensure robustness of the findings.
Results: In the bidirectional MR analysis, the IVW analysis identified two inflammatory cytokines as risk factors for hypertensive renal disease: interferon-gamma levels (OR 1.500, 95% CI 1.130-1.992) and oncostatin-M levels (OR 1.414, 95% CI 1.086-1.841). Additionally, the study identified three cytokines as protective factors against hypertensive renal disease: CD40L receptor levels (OR 0.817, 95% CI 0.679-0.983), interleukin-10 receptor subunit beta levels (OR 0.829, 95% CI 0.703-0.976), and interleukin-20 receptor subunit alpha levels (OR 0.725, 95% CI 0.549-0.957). These results highlight the complex role of inflammatory cytokines in the progression of hypertensive renal disease. No evidence of horizontal pleiotropy, heterogeneity, or reverse causality was found in the above results.
Conclusion: This Mendelian randomization analysis identified inflammatory cytokines associated with hypertensive renal disease, providing a foundation for future mechanistic research and potential therapeutic targets.
Keywords: Genetic epidemiology; Hypertensive renal disease; Inflammatory cytokines; Mendelian randomization.
© 2025. The Author(s), under exclusive licence to Springer Nature B.V.
Conflict of interest statement
Declarations. Conflict of interest: The authors declare no competing interests.
Similar articles
-
Inflammatory cytokines mediate the gut microbiota-EGPA subtype link: a Mendelian randomization study.Clin Rheumatol. 2025 Jul;44(7):3061-3071. doi: 10.1007/s10067-025-07526-5. Epub 2025 Jun 12. Clin Rheumatol. 2025. PMID: 40500572
-
Ischemic Stroke May Increase the Risk of Crohn's Disease and Ulcerative Colitis: Evidence from a Bidirectional Mendelian Randomization Study.World Neurosurg. 2025 Apr;196:123718. doi: 10.1016/j.wneu.2025.123718. Epub 2025 Mar 13. World Neurosurg. 2025. PMID: 39929265
-
Analysis of the correlation between inflammatory cytokines and glioblastoma: A Mendelian randomization study.Medicine (Baltimore). 2025 May 30;104(22):e42137. doi: 10.1097/MD.0000000000042137. Medicine (Baltimore). 2025. PMID: 40441232 Free PMC article.
-
Planned early delivery versus expectant management for hypertensive disorders from 34 weeks gestation to term.Cochrane Database Syst Rev. 2017 Jan 15;1(1):CD009273. doi: 10.1002/14651858.CD009273.pub2. Cochrane Database Syst Rev. 2017. PMID: 28106904 Free PMC article.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
References
-
- Stompor T, Perkowska-Ptasińska A (2020) Hypertensive kidney disease: a true epidemic or rare disease? Pol Arch Intern Med 130(2):130–139 - PubMed
-
- Shao X, Zhang P, Yao X, et al. (2016) Trends of demographic and primary disease in new end-stage renal disease dialysis patients of Zhejiang province from 2008 to 2013, F
-
- System U R D (2001) USRDS 2001 Annual Data Report: Atlas of End-Stage Renal Disease in the United States [M]. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases
LinkOut - more resources
Full Text Sources
Research Materials